DK0796609T3 - Remedy for alopecia - Google Patents

Remedy for alopecia

Info

Publication number
DK0796609T3
DK0796609T3 DK97104606T DK97104606T DK0796609T3 DK 0796609 T3 DK0796609 T3 DK 0796609T3 DK 97104606 T DK97104606 T DK 97104606T DK 97104606 T DK97104606 T DK 97104606T DK 0796609 T3 DK0796609 T3 DK 0796609T3
Authority
DK
Denmark
Prior art keywords
anticancer agents
present
antialopecia agent
antialopecia
agent
Prior art date
Application number
DK97104606T
Other languages
Danish (da)
Inventor
Yokichi Matsui
Kyoya Takahata
Original Assignee
Suntory Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntory Ltd filed Critical Suntory Ltd
Application granted granted Critical
Publication of DK0796609T3 publication Critical patent/DK0796609T3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
    • A23F3/00—Tea; Tea substitutes; Preparations thereof
    • A23F3/16—Tea extraction; Tea extracts; Treating tea extract; Making instant tea
    • A23F3/163—Liquid or semi-liquid tea extract preparations, e.g. gels or liquid extracts in solid capsules
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
    • A23F3/00—Tea; Tea substitutes; Preparations thereof
    • A23F3/16—Tea extraction; Tea extracts; Treating tea extract; Making instant tea
    • A23F3/30—Further treatment of dried tea extract; Preparations produced thereby, e.g. instant tea
    • A23F3/32—Agglomerating, flaking or tabletting or granulating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Birds (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Bakery Products And Manufacturing Methods Therefor (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Non-Alcoholic Beverages (AREA)
  • Tea And Coffee (AREA)
  • Fish Paste Products (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

The present invention provides an antialopecia agent which is a drug for protecting, reducting or preventing alopecia frequently occurring as the side effect of anticancer agents, inflicts neither any pain nor unpleasantness on patients under the treatment with anticancer agents and has a high safety; and foods or beverages containing this antialopecia agent. The antialopecia agent of the present invention is characterized by containing oolong tea extract as the active ingredient.
DK97104606T 1996-03-18 1997-03-18 Remedy for alopecia DK0796609T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP6118696 1996-03-18
JP9059494A JPH09309840A (en) 1996-03-18 1997-03-13 Anti-hair loss agent

Publications (1)

Publication Number Publication Date
DK0796609T3 true DK0796609T3 (en) 2003-11-17

Family

ID=26400541

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97104606T DK0796609T3 (en) 1996-03-18 1997-03-18 Remedy for alopecia

Country Status (8)

Country Link
US (1) US6713093B2 (en)
EP (1) EP0796609B1 (en)
JP (1) JPH09309840A (en)
AT (1) ATE248571T1 (en)
DE (1) DE69724490T2 (en)
DK (1) DK0796609T3 (en)
ES (1) ES2206623T3 (en)
PT (1) PT796609E (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4321957B2 (en) * 2000-09-11 2009-08-26 株式会社資生堂 Inhibitor against male pattern hair loss
KR20040004374A (en) * 2000-09-11 2004-01-13 가부시키가이샤 시세이도 Hair nourishments and method of screening the same
US20080317882A1 (en) * 2004-05-28 2008-12-25 Kenei Shimada Composistion Comprising Fremented tea Extract as the Main Component and Having Effect of Elevation Adiponectin Level
JP2007197387A (en) * 2006-01-27 2007-08-09 Maruzen Pharmaceut Co Ltd TESTOSTERONE 5alpha-REDUCTASE INHIBITOR
TWI386168B (en) * 2006-05-18 2013-02-21 Yakult Honsha Kk Guava leaf extract powder and preparation method thereof
PT2689774T (en) 2011-03-21 2019-04-05 Broda Tech Co Ltd Reversely thermo-reversible hydrogel compositions
CN104127838A (en) * 2014-07-05 2014-11-05 济南伟传信息技术有限公司 Traditional Chinese medicine prescription for treating cancer

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61137809A (en) * 1984-12-07 1986-06-25 Sanai Kagaku Kogyo Kk Cosmetic
US4717579A (en) 1986-05-07 1988-01-05 The Procter & Gamble Co. Flowable frozen tea mix concentrate which contains high levels of sugar
JPH03109313A (en) * 1989-04-21 1991-05-09 Yukihiro Takahashi Production of hair tonic
US5605929A (en) 1992-05-27 1997-02-25 Arch Development Corp. Methods and compositions for inhibiting 5α-reductase activity
JPH0640860A (en) * 1992-07-16 1994-02-15 Takeo Kaneko Hair tonic
DE4334734C2 (en) 1992-10-13 1997-04-30 House Foods Corp Process for the preparation of an instantly soluble powder

Also Published As

Publication number Publication date
US20020160058A1 (en) 2002-10-31
PT796609E (en) 2004-01-30
DE69724490D1 (en) 2003-10-09
DE69724490T2 (en) 2004-07-08
JPH09309840A (en) 1997-12-02
ES2206623T3 (en) 2004-05-16
ATE248571T1 (en) 2003-09-15
EP0796609A2 (en) 1997-09-24
EP0796609B1 (en) 2003-09-03
EP0796609A3 (en) 1999-03-03
US6713093B2 (en) 2004-03-30

Similar Documents

Publication Publication Date Title
NZ334124A (en) Use of the chelating agent clioquinol, with vitamin B12 for the manufacture of a pharmaceutical composition for the treatment of alzheimer's disease
IL138723A0 (en) Antitumor agent
WO1999063977A3 (en) Pharmaceutical combination comprising a tricyclic compound and at least one of zolpidem, zopiclone, triazolam and brotizolam for treating or preventing sleep disorders
ATE110963T1 (en) AGENTS FOR INHIBITING ALPHA-AMYLASE ACTIVITY.
PL309334A1 (en) Synthetic catalytical scavenger of free radicals, preferably used as antioxidants in preventing and treating pathogenic states
PT1411938E (en) USE OF CYCLOPAMINE FOR THE PREPARATION OF A MEDICATION FOR THE TREATMENT OF PSORIASIS
WO2001021259A3 (en) Use and compositions for treating platelet-related disorders using anagrelide
MXPA01012184A (en) Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria.
WO2002051433A3 (en) Use of artemin, a member of the gdnf ligand family for preparing a neuroprotective medicament
WO2002098345A8 (en) Use of an antioxidant for treating and/or preventing surface ocular disorders
PT1040830E (en) MEDICATION FOR NEURODEGENERATIVE DISEASES
BG105575A (en) Method and agent for the treatment of cerebral ischaemia
WO2002053106A3 (en) Autoantigen composition
EP0819433A3 (en) Compositions for increasing the efficacy of cancer drugs with tea catechin and/or theaflavin
ES2077703T3 (en) GLUCOSILTRANSFERASE INHIBITORS, AS WELL AS METHODS FOR THE PREVENTION OF DENTAL CARIES AND ANTI-CARIES FOODS USED BY THESE INHIBITORS.
PT1102586E (en) USE OF GINKGO BILOBA EXTRACTS FOR THE PREPARATION OF A MEDICATION FOR THE TREATMENT OF AMIOTROPHIC LATERAL SCLEROSIS
DK0796609T3 (en) Remedy for alopecia
AU7862401A (en) Pharmaceutical compostion comprising trkaig2 for use in the prevention and/or treatment of cancer
PL354413A1 (en) Composition for the prevention and/or treatment of circulatory disorders, comprising derivatives of l-carnitine and extracts ofginkgo biloba
TR200102512T2 (en) The use of saredutan and its pharmaceutically acceptable salts for the preparation of medicinal products useful in the treatment or prevention of all mental disorders, adaptation disorders and various anxiety-depression disorders.
EP1297849A4 (en) Remedial agent for optic nerve disease and the like
EP0400219A3 (en) Use of creosote as an antispasmodic agent
WO1997033620A3 (en) Compounds for treating tumours
WO2002049647A3 (en) Novel therapeutic use of a thienylcyclohexylamine derivative
EP1121936A4 (en) Preventives and/or remedies for obesity